CHLORPHENIRAMINE MALEATE, IBUPROFEN, AND PHENYLEPHRINE HYDROCHLORIDE

CHLORPHENIRAMINE MALEATE, IBUPROFEN, AND PHENYLEPHRINE HYDROCHLORIDE was reported 393 times

CHLORPHENIRAMINE MALEATE, IBUPROFEN, AND PHENYLEPHRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MOUTH BREATHING 1 0.0023
1 DRUG EFFECT PROLONGED 1 0.0018
2 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
3 NASAL OEDEMA 2 0.0011
4 CEREBRAL PALSY 1 0.0011
5 PRODUCT COATING ISSUE 1 0.0010
6 RENAL MASS 2 0.0010
7 PRODUCT BLISTER PACKAGING ISSUE 1 0.0010
8 DRUG EFFECT DELAYED 4 0.0009
9 AXILLARY PAIN 1 0.0007
10 HYPOSMIA 1 0.0007
11 POOR QUALITY DRUG ADMINISTERED 4 0.0006
12 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
13 PRODUCT LABEL ISSUE 4 0.0006
14 LAZINESS 1 0.0006
15 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
16 PRODUCT TAMPERING 1 0.0006
17 PARANASAL SINUS DISCOMFORT 2 0.0005
18 DRUG EFFECT INCOMPLETE 18 0.0005
19 PRE-EXISTING CONDITION IMPROVED 3 0.0005
20 REACTION TO DRUG EXCIPIENTS 1 0.0005
21 BREATH ODOUR 1 0.0004
22 EXPIRED DRUG ADMINISTERED 2 0.0004
23 ABDOMINAL TENDERNESS 2 0.0004
24 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
25 LIP BLISTER 1 0.0004
26 WRONG PATIENT RECEIVED MEDICATION 1 0.0004
27 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
28 DUODENITIS 1 0.0003
29 SKIN EROSION 1 0.0003
30 DRY THROAT 3 0.0003
31 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
32 DRUG SCREEN POSITIVE 2 0.0003
33 HEPATIC LESION 1 0.0002
34 OCULAR ICTERUS 1 0.0002
35 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
36 LACERATION 2 0.0002
37 EXPIRED PRODUCT ADMINISTERED 7 0.0002
38 PRODUCT PACKAGING ISSUE 2 0.0002
39 FEELING JITTERY 4 0.0002
40 PRODUCT COLOUR ISSUE 1 0.0002
41 MOUTH SWELLING 1 0.0002
42 PRODUCT LABEL CONFUSION 1 0.0002
43 NASAL CONGESTION 10 0.0002
44 SINUS HEADACHE 1 0.0002
45 NASAL DRYNESS 1 0.0002
46 SOMNOLENCE 32 0.0002
47 SINUS DISORDER 3 0.0002
48 METASTASES TO LYMPH NODES 1 0.0001
49 ORAL DISORDER 1 0.0001
50 PSYCHIATRIC SYMPTOM 1 0.0001
51 FEELING DRUNK 1 0.0001
52 SNEEZING 3 0.0001
53 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
54 MULTIPLE ALLERGIES 1 0.0001
55 NASAL DISCOMFORT 1 0.0001
56 RESPIRATORY TRACT CONGESTION 2 0.0001
57 ASPHYXIA 1 0.0001
58 MENSTRUAL DISORDER 1 0.0001
59 DRUG INEFFECTIVE 150 0.0001
60 COLD SWEAT 2 0.0001
61 HEAD DISCOMFORT 2 0.0001
62 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
63 OPTIC NEURITIS 1 0.0001
64 BRAIN NEOPLASM 1 0.0001
65 IRON DEFICIENCY ANAEMIA 1 0.0001
66 RECALLED PRODUCT ADMINISTERED 1 0.0001
67 PRODUCT PHYSICAL ISSUE 2 0.0001
68 EXTRA DOSE ADMINISTERED 4 0.0001
69 NERVOUSNESS 5 0.0001
70 INJECTION SITE DISCOMFORT 1 0.0001
71 BODY HEIGHT DECREASED 1 0.0001
72 RHINORRHOEA 6 0.0001
73 GASTROINTESTINAL PAIN 1 0.0001
74 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
75 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
76 INTERNAL HAEMORRHAGE 1 0.0001
77 GASTRIC HAEMORRHAGE 1 0.0001
78 FEELING ABNORMAL 20 0.0001
79 EYE SWELLING 3 0.0001
80 AGEUSIA 2 0.0001
81 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
82 PRODUCT COMPLAINT 2 0.0001
83 INJECTION SITE INDURATION 1 0.0001
84 EYE HAEMORRHAGE 1 0.0001
85 MALIGNANT MELANOMA 1 0.0001
86 SINUS CONGESTION 1 0.0001
87 PRODUCT TASTE ABNORMAL 1 0.0001
88 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
89 ANOSMIA 1 0.0001
90 INTENTIONAL PRODUCT MISUSE 6 0.0001
91 PALPITATIONS 8 0.0001
92 HYPOAESTHESIA ORAL 1 0.0001
93 METASTASES TO BONE 1 0.0001
94 HEART RATE INCREASED 6 0.0001
95 DRUG EFFECT DECREASED 3 0.0001
96 CHOKING 1 0.0001
97 PRODUCT ADMINISTRATION ERROR 1 0.0000
98 INJECTION SITE WARMTH 1 0.0000
99 RETCHING 1 0.0000
100 POOR QUALITY SLEEP 1 0.0000
101 CHROMATURIA 1 0.0000
102 ABDOMINAL PAIN UPPER 9 0.0000
103 PRESYNCOPE 1 0.0000
104 ABASIA 1 0.0000
105 ANAPHYLACTIC SHOCK 1 0.0000
106 SEDATION 1 0.0000
107 HYPERSENSITIVITY 7 0.0000
108 DRY MOUTH 3 0.0000
109 THROAT TIGHTNESS 1 0.0000
110 RESPIRATORY DISORDER 1 0.0000
111 IRRITABILITY 2 0.0000
112 LACRIMATION INCREASED 1 0.0000
113 CONDITION AGGRAVATED 10 0.0000
114 DISCOMFORT 2 0.0000
115 FEELING HOT 2 0.0000
116 EMOTIONAL DISORDER 1 0.0000
117 LIMB DISCOMFORT 1 0.0000
118 DIZZINESS 16 0.0000
119 SWOLLEN TONGUE 1 0.0000
120 MOOD SWINGS 1 0.0000
121 HIP FRACTURE 1 0.0000
122 DRUG INTOLERANCE 3 0.0000
123 DYSPEPSIA 3 0.0000
124 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
125 BACK PAIN 7 0.0000
126 INSOMNIA 8 0.0000
127 SKIN DISORDER 1 0.0000
128 EYE PRURITUS 1 0.0000
129 ANGER 1 0.0000
130 BURNING SENSATION 2 0.0000
131 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
132 MOBILITY DECREASED 2 0.0000
133 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
134 INJECTION SITE MASS 1 0.0000
135 DYSGEUSIA 2 0.0000
136 DYSPNOEA 15 0.0000
137 BLOOD PRESSURE INCREASED 4 0.0000
138 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
139 INFLUENZA LIKE ILLNESS 2 0.0000
140 TREMOR 4 0.0000
141 POLLAKIURIA 1 0.0000
142 HYPERHIDROSIS 3 0.0000
143 PRODUCT QUALITY ISSUE 3 0.0000
144 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
145 SWELLING 2 0.0000
146 RASH ERYTHEMATOUS 1 0.0000
147 MALAISE 9 0.0000
148 CHEST DISCOMFORT 2 0.0000
149 MUSCULOSKELETAL PAIN 1 0.0000
150 DERMATITIS ATOPIC 1 0.0000
151 RASH PRURITIC 1 0.0000
152 PRURITUS 7 0.0000
153 URTICARIA 3 0.0000
154 ABDOMINAL DISCOMFORT 3 0.0000
155 MYALGIA 3 0.0000
156 INCORRECT DOSE ADMINISTERED 4 0.0000
157 LETHARGY 1 0.0000
158 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
159 THERAPEUTIC RESPONSE DECREASED 1 0.0000
160 VERTIGO 1 0.0000
161 PAIN 10 0.0000
162 VISUAL IMPAIRMENT 2 0.0000
163 PRODUCT USE ISSUE 3 0.0000
164 GAIT DISTURBANCE 3 0.0000
165 FATIGUE 12 0.0000
166 SWELLING FACE 1 0.0000
167 DEHYDRATION 2 0.0000
168 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
169 VISION BLURRED 2 0.0000
170 INJECTION SITE REACTION 1 0.0000
171 HEADACHE 9 0.0000
172 SLEEP DISORDER 1 0.0000
173 SKIN BURNING SENSATION 1 0.0000
174 CONSTIPATION 3 0.0000
175 UNDERDOSE 1 0.0000
176 AGITATION 1 0.0000
177 EPISTAXIS 1 0.0000
178 HYPOAESTHESIA 2 0.0000
179 HOT FLUSH 1 0.0000
180 ACNE 1 0.0000
181 DIABETES MELLITUS 1 0.0000
182 PARAESTHESIA 2 0.0000
183 INJECTION SITE BRUISING 1 0.0000
184 RENAL IMPAIRMENT 1 0.0000
185 BALANCE DISORDER 1 0.0000
186 MYOCARDIAL INFARCTION 2 0.0000
187 NAUSEA 9 0.0000
188 OROPHARYNGEAL PAIN 1 0.0000
189 COUGH 3 0.0000
190 MIGRAINE 1 0.0000
191 CONTUSION 1 0.0000
192 SYNCOPE 1 0.0000
193 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
194 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
195 SINUSITIS 1 0.0000
196 ERYTHEMA 2 0.0000
197 ILLNESS 1 0.0000
198 HAEMORRHAGE 1 0.0000
199 DIARRHOEA 6 0.0000
200 INFLUENZA 1 0.0000
201 PYREXIA 3 0.0000
202 SEIZURE 1 0.0000
203 VOMITING 4 0.0000
204 INJECTION SITE ERYTHEMA 1 0.0000
205 LOSS OF CONSCIOUSNESS 1 0.0000
206 MEMORY IMPAIRMENT 1 0.0000
207 WEIGHT DECREASED 2 0.0000
208 ANXIETY 2 0.0000
209 PERIPHERAL SWELLING 1 0.0000
210 DRUG DEPENDENCE 1 0.0000
211 COVID-19 1 0.0000
212 NO ADVERSE EVENT 1 0.0000
213 MUSCLE SPASMS 1 0.0000
214 NASOPHARYNGITIS 1 0.0000
215 CHEST PAIN 1 0.0000
216 ASTHENIA 2 0.0000
217 BLOOD GLUCOSE INCREASED 1 0.0000
218 ALOPECIA 1 0.0000
219 ARTHRALGIA 2 0.0000
220 HYPERTENSION 1 0.0000
221 OVERDOSE 1 0.0000
222 RASH 2 0.0000
223 OFF LABEL USE 4 0.0000
224 WEIGHT INCREASED 1 0.0000
225 DEPRESSION 1 0.0000
226 DECREASED APPETITE 1 0.0000
227 ABDOMINAL PAIN 1 0.0000
228 PAIN IN EXTREMITY 1 0.0000
229 INJECTION SITE PAIN 1 0.0000
230 DEATH 1 0.0000